Agilon Health Inc. (NYSE: AGL) reported Q3 EPS of ($0.08), $0.03 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.13 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.